{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-077920","form_type":"8-K","ticker":"HYPD","cik":"0001682639","company_name":"HYPERION DEFI, INC.","filed_at":"2022-07-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.649557+00:00","generated_at":"2026-06-24T19:43:35.353356+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Eyenovia appoints Drs. Strahlman and Palanki as independent directors, board expands to 8 seats","bullets":["Both appointments effective July 1, 2022; board increases from 6 to 8 members.","Dr. Strahlman, former EVP R&D at BD and ex-CMO at GSK, joins audit and compensation committees.","Dr. Palanki, EVP Commercial Strategy at REGENXBIO with Santen/Genentech background, joins compensation committee.","Both directors determined independent under SEC and Nasdaq rules."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-077920","json":"https://secwatch.observer/filing/0001104659-22-077920.json","markdown":"https://secwatch.observer/filing/0001104659-22-077920.md","text":"https://secwatch.observer/filing/0001104659-22-077920.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1682639/000110465922077920/0001104659-22-077920-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1682639/000110465922077920/tm2220584d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T19:43:35.353356+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1061966d9c","claim":"Dr. Ellen R. Strahlman was appointed as Director at HYPERION DEFI, INC..","evidence_excerpt":"On July 1, 2022, the Board of Directors (the “Board”) of Eyenovia, Inc. (the “Company”) appointed Dr. Ellen R. Strahlman and Dr. Ram Palanki as members of the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1682639/000110465922077920/0001104659-22-077920-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"43e0c6ad28","claim":"Dr. Ram Palanki was appointed as Director at HYPERION DEFI, INC..","evidence_excerpt":"On July 1, 2022, the Board of Directors (the “Board”) of Eyenovia, Inc. (the “Company”) appointed Dr. Ellen R. Strahlman and Dr. Ram Palanki as members of the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1682639/000110465922077920/0001104659-22-077920-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}